WHERE TO WATCH
Cannabis Stocks Fall After FDA Hearings On CBD Regulation
June 4, 2019
What do the FDA hearings mean for cannabis stocks and the U.S. CBD market? Richard Batenburg III, Investor Relations at Cliintel Capital Management Group, joined Cheddar to discuss.
Carta CEO Details Plans For 'Private Stock Market'
Jun 4, 2019
CannaBiz: Illinois Set To Legalize Recreational Marijuana, Cronos Group Expects to Enter U.S. CBD Market & The FDA Hearings On CBD Regulation Are Impacting Pot Stocks
Illinois is set to be the first state in the U.S. to legalize commercial recreational marijuana through its legislature after lawmakers on voted in favor of a legalization bill. Rep. Kelly Cassidy, a Democrat from Chicago, joined Cheddar to discuss. Canadian cannabis producer Cronos Group plans to leverage its U.S. relationships, including an investment from Altria, to launch CBD products in the U.S. ー perhaps as soon as later this year. Mike Gorenstein, Cronos Group CEO and co-founder spoke to Cheddar in an exclusive interview. What do the FDA hearings mean for cannabis stocks and the U.S. CBD market? Richard Batenburg III, Investor Relations at Cliintel Capital Management Group, joined Cheddar to discuss.
Jun 11, 2019
Emerald Exchange Empowers Farmers and Consumers With 'Craft' Cannabis Events
Emerald Exchange hosts farmers market-style events to connect small batch cannabis cultivators from Northern California with cannabis enthusiasts in Southern California.
Jun 11, 2019
Tilray Announces Plan To Merge With Its Largest Shareholder Privateer Holdings
Tilray is merging with Privateer Holdings. The cannabis-focused private equity fund is backed by Silicon Valley investor Peter Thiel and holds about 77% of Tilray's outstanding shares.Todd Harrison, Founding Partner & Chief Investment Officer of CB1 Capital Management, joined Cheddar to discuss.